Search By:
Products
Injury
Topic
Company
Industry
Schering-Plough might have harmed direct purchasers of K-Dur 20 by paying $90 million to delay the manufacture of a generic equivalent.
Investigation Source
- Nationwide
Investigation Scope
Category Information
Investigation Topics
- Over Charge
- Price Fixing
- Overcharging for Drug
Products or Services
- Doctors
- Hospitals
- Healthcare Organizations
- K-Dur 20
- Pharmacists
Injury Type
- Monetary Loss
Investigation Details
Investigation and a pending class action lawsuit against Schering-Plough, Upsher-Smith and American Home Products on behalf of a class of direct purchasers of the brand-name drug K-Dur 20.
K-Dur 20 is a potassium chloride supplement used to treat patients with depleted potassium. The class action lawsuit alleges that Schering-Plough, Upsher-Smith, and American Home Products violated federal antitrust law by entering into written, anticompetitive agreements under which Schering-Plough paid its rival generic manufacturers, Upsher-Smith and American Home Products, $90 million to delay the market entry of their generic versions of K-Dur 20. The class claims that, as a result of these anti-competitive agreements, purchasers of K-Dur 20 were forced to pay artificially high prices for the drug entity sold as K-Dur 20. One defendant, American Home Products, has agreed to settle with a class of direct purchasers of K-Dur 20 for $2.1 million and other consideration. Litigation against the remaining defendants is ongoing.
Do not change medications without first consulting your doctor.
K-Dur 20 is a potassium chloride supplement used to treat patients with depleted potassium. The class action lawsuit alleges that Schering-Plough, Upsher-Smith, and American Home Products violated federal antitrust law by entering into written, anticompetitive agreements under which Schering-Plough paid its rival generic manufacturers, Upsher-Smith and American Home Products, $90 million to delay the market entry of their generic versions of K-Dur 20. The class claims that, as a result of these anti-competitive agreements, purchasers of K-Dur 20 were forced to pay artificially high prices for the drug entity sold as K-Dur 20. One defendant, American Home Products, has agreed to settle with a class of direct purchasers of K-Dur 20 for $2.1 million and other consideration. Litigation against the remaining defendants is ongoing.
Do not change medications without first consulting your doctor.
Defendant Details
| Name (Stock Symbol) | Brief Description |
|---|---|
| Schering-Plough Corporation (SGP) | Schering-Plough Corporation discovers, develops, manufactures, and sells pharmaceuticals worldwide. |
| Upsher-Smith Laboratories, Inc. | Upsher-Smith Laboratories, Inc. is a pharmaceutical company. |
| American Home Products (WYE) | American Home Products changed its name to Wyeth. It is one of the largest pharmaceutical companies in the world. |